Pharmacy benefit manager Prime Therapeutics (Prime) announced the results of a study on the utilization of Strattera(R) (atomoxetine) for treating attention deficit hyperactivity disorder (ADHD) in children.
Oncolytics Biotech Inc. (“Oncolytics”) (TSX:ONC, NASDAQ:ONCY) announced that subsequent to the regulatory review period for this submission, it is proceeding with a Phase II trial to evaluate the intravenous administration of REOLYSIN? in patients with various sarcomas that have metastasized to the lung.
Nutrition experts at the Moores UCSD Cancer Center and Scripps Clinic in Del Mar are seeking obese men and women to participate in a research study for weight loss employing an investigational combination drug therapy and behavioral modification.
A Northwestern University researcher has used adult stem cell injections to reset the immune systems of patients with early-onset Type 1 diabetes. After the therapy, patients no longer needed to take insulin for up to 35 months.
The breast cancer death rate is declining significantly and more women are surviving longer, according to a special report in Canadian Cancer Statistics 2007, released by the Canadian Cancer Society.
The World Health Organization (WHO) is committed to work towards universal access, by 2010, to HIV prevention services and to treatment and care for people living with HIV/AIDS.
Recently, there have been several advances in treatment and therapy for breast cancer. However, the rate of recurrence is still unpredictable. Researchers at West Virginia University have discovered a gene pattern for identifying a patient?s odds of breast cancer recurrence.
A therapy that includes stem cell transplantation induced extended insulin independence in patients with type 1 diabetes mellitus, according to a preliminary study in the April 11 issue of JAMA.
Kent County Cricket Club?s first team players were put to the test by University of Kent at Medway staff and students in a pre-season fitness session.
Measuring a man?s daily calcium intake is an effective way of identifying prostate cancer patients with a higher than average risk of osteoporosis, according to the April issue of the urology journal BJU International.